
A doctor by training who now runs research, development and medical affairs at one of neuroscience's most watched biopharma companies - and keeps the patient at the center of every decision.
Alkermes spent decades teaching medicines to last longer. Now the neuroscience company is trying something harder: building a business around the brain's switches for addiction, psychosis and wakefulness.